NCT05031143View on ClinicalTrials.gov

Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

February 20, 2021

Study Completion Date

August 24, 2021

Conditions
Vogt Koyanagi Harada Disease
Interventions
DRUG

Suprachoroidal Triamcinolone acetonide injection for serous retinal detachment in VKH disease

Suprachoroidal steroid injection for management of serous retinal detachment in VKH disease

Trial Locations (1)

13511

Ophthalmology department,Benha University and Ebsar eye center,Benha,EGYPT, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT05031143 - Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment | Biotech Hunter | Biotech Hunter